Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A B Boucher

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2008
[HIV should become a notifiable disease]B J M Vlaminckx, C A B Boucher
Handbook of Experimental Pharmacology|December 3, 2008
Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phasesM Nijhuis, N M van Maarseveen, C A B Boucher
The Netherlands Journal of Medicine|June 15, 2005
Hepatitis C virus and human immunodeficiency virus coinfection: where do we stand?J E Arends, C A B Boucher, A I M Hoepelman
The Netherlands Journal of Medicine|December 9, 2017
Ending the epidemic: Critical role of primary HIV infectionH A B Prins, A Verbon, C A B Boucher, et al.
Journal of Internal Medicine|September 21, 2011
HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistanceB E Nichols, C A B Boucher, D A M C van de Vijver
Nederlands Tijdschrift Voor Geneeskunde|December 14, 2004
[Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells]M C A Smit, M H Haverkamp, A J L Weersink, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 22, 2005
[Post-exposure prophylaxis following exposure to HIV: adaptation to the situation may be indicated]A M J Wensing, M M E Schneider, C A M Schurink, et al.
Journal of Virological Methods|December 22, 2005
A novel real-time PCR assay to determine relative replication capacity for HIV-1 protease variants and/or reverse transcriptase variantsN M van Maarseveen, M C D G Huigen, D de Jong, et al.
HIV Medicine|September 20, 2012
Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutationsM Pingen, M E van der Ende, A M Wensing, et al.
HIV Medicine|September 15, 2005
Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapyJ B van den Berg, E Hak, S C J M Vervoort, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2008
[HIV should become a notifiable disease]B J M Vlaminckx, C A B Boucher
Handbook of Experimental Pharmacology|December 3, 2008
Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phasesM Nijhuis, N M van Maarseveen, C A B Boucher
The Netherlands Journal of Medicine|June 15, 2005
Hepatitis C virus and human immunodeficiency virus coinfection: where do we stand?J E Arends, C A B Boucher, A I M Hoepelman
The Netherlands Journal of Medicine|December 9, 2017
Ending the epidemic: Critical role of primary HIV infectionH A B Prins, A Verbon, C A B Boucher, et al.
Journal of Internal Medicine|September 21, 2011
HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistanceB E Nichols, C A B Boucher, D A M C van de Vijver
Nederlands Tijdschrift Voor Geneeskunde|December 14, 2004
[Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells]M C A Smit, M H Haverkamp, A J L Weersink, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 22, 2005
[Post-exposure prophylaxis following exposure to HIV: adaptation to the situation may be indicated]A M J Wensing, M M E Schneider, C A M Schurink, et al.
Journal of Virological Methods|December 22, 2005
A novel real-time PCR assay to determine relative replication capacity for HIV-1 protease variants and/or reverse transcriptase variantsN M van Maarseveen, M C D G Huigen, D de Jong, et al.
HIV Medicine|September 20, 2012
Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutationsM Pingen, M E van der Ende, A M Wensing, et al.
HIV Medicine|September 15, 2005
Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapyJ B van den Berg, E Hak, S C J M Vervoort, et al.
Pageof 2